logo

For the Inventor, By the Inventor

Half Moon Bay, CA, United States of America

Joshua Schultz

This inventor holds 4 USPTO granted patents. Top assignee: Amgen Inc.. Active years: 2006-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joshua Schultz. Retrieved from https://idiyas.com/inventor/joshua-schultz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Half Moon Bay, CA (US) (2006 - 2010)
  • Ballston Lake, NY (US) (2012)

Company Filing History:

goldMedal4 out of 2,072 
 
Amgen Inc.
 patents

Years Active: 2006-2012

Loading Chart...
4 patents (USPTO):Explore Patents
1. 8257934 - Screening methods using sitosterolemia susceptibility gene (SSG) polypeptides (2012-09-04),
2. 7662376 - Sitosterolemia susceptibility gene (SSG): compositions and methods of use (2010-02-16),
3. 7229816 - Sitosterolemia susceptibility gene (SSG) polypeptides (2007-06-12),
4. 7033810 - Sitosterolemia susceptibility gene (SSG): compositions and methods of use (2006-04-25),

Title: Innovations of Joshua Schultz in Cholesterol Transport

Introduction

Joshua Schultz is an accomplished inventor based in Half Moon Bay, CA (US). He has made significant contributions to the field of cholesterol transport, holding a total of 4 patents. His work focuses on the diagnosis and treatment of cholesterol-associated disorders, particularly sitosterolemia.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Screening methods using sitosterolemia susceptibility gene (SSG) polypeptides." This invention provides nucleic acids encoding a novel ABC family cholesterol transporter, SSG. The disclosed sequences can be utilized for various purposes, including the diagnosis and treatment of cholesterol-associated disorders, such as sitosterolemia. Another notable patent is "Sitosterolemia susceptibility gene (SSG): compositions and methods of use," which also centers around the SSG transporter and its applications in medical diagnostics and treatment.

Career Highlights

Joshua Schultz is currently employed at Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to further his research and development in the field of cholesterol transport and its implications for human health.

Collaborations

Joshua has collaborated with notable colleagues, including Hui Tian and Bei Shan, to advance his research and innovations in cholesterol transport.

Conclusion

Joshua Schultz's contributions to the field of cholesterol transport through his innovative patents highlight his dedication to improving health outcomes related to cholesterol-associated disorders. His work continues to pave the way for advancements in medical diagnostics and treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…